featured
Long-Term Results of Dose-Dense Paclitaxel and Carboplatin Versus Conventional Paclitaxel and Carboplatin for Treatment of Advanced Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (JGOG 3016): A Randomised, Controlled, Open-Label Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology